MedPath

Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA)

Phase 4
Completed
Conditions
Short Stature Born Small for Gestational Age (SGA)
Interventions
Registration Number
NCT01859949
Lead Sponsor
Pfizer
Brief Summary

To assess the long-term safety of Genotropin(somatropin) on Small for Gestational Age (SGA) without epiphyseal closing.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
62
Inclusion Criteria

Children with short stature due to SGA who received treatment in the study GENASG-0021-002.

Exclusion Criteria
  • Children who have any chronic disease requiring treatment with steroid hormone that may affect growth promotion including estrogen, androgen, anabolic hormone, and corticosteroids (except those for external use), and have received the treatment.
  • Children who have received radiotherapy or chemotherapy.
  • Children who have serious cardiac disease, renal disease, or hepatic disease.
  • Children who have diabetes mellitus with a manifestation of abnormal glucose metabolism.
  • Children who have serious chronic disease.
  • Children who have malignant tumor.
  • Children who are allergic to m-cresol.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Genotropin (somatropin)Genotropin (somatropin)-
Primary Outcome Measures
NameTimeMethod
Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)Month 12 (at the end of previous study) to 156
Secondary Outcome Measures
NameTimeMethod
Height SDS for Chronological AgeMonth 12 (at the end of previous study) to 156

Height SDS is calculated as following formula; Height SDS = (height - mean) / standard deviation,

where mean and standard deviation were based on standard Japanese values on the participant age and gender.

The scores were centred around zero. Negative score indicated a participant was smaller for their age/gender.

Height Velocity SDS for Bone AgeMonth 12 (at the end of previous study) to 156

To measure bone age, X-ray images of the left hand were centrally assessed by an independent specialist using the Tanner-Whitehouse 2 (RUS) method standardized for Japanese children.

Height velocity is the yearly height gain. Height velocity SDS for bone age is calculated as following formula; Height velocity SDS = (height velocity - mean) / standard deviation,

where mean and standard deviation were based on standard Japanese values corresponding to bone age and gender.

The scores were centred around zero. Negative score indicated a participant was smaller for their age/gender.

Height Velocity Standard Deviation Score (SDS) for Chronological AgeMonth 12 (at the end of previous study) to 156

Height velocity is the yearly height gain. Height velocity SDS is calculated as following formula; Height velocity SDS = (height velocity - mean) / standard deviation,

where mean and standard deviation were based on standard Japanese values of the participants age and gender.

The scores were centred around zero. Negative score indicated a participant was smaller for their age/gender.

Height VelocityMonth 12 (at the end of previous study) to 156

Height velocity is the yearly height gain

Height SDS for Bone AgeMonth 12 (at the end of previous study) to 156

To measure bone age, X-ray images of the left hand were centrally assessed by an independent specialist using the Tanner-Whitehouse 2 (RUS) method standardized for Japanese children.

Height SDS for bone age is calculated as following formula; Height SDS = (height - mean) / standard deviation,

where mean and standard deviation were based on standard Japanese values corresponding to bone age and gender.

The scores were centred around zero. Negative score indicated a participant was smaller for their age/gender.

Trial Locations

Locations (19)

Kitasato University Hospital

🇯🇵

Sagamihara, Kanagawa, Japan

Tohoku University Hospital

🇯🇵

Sendai, Miyagi, Japan

Hiroshima City Hospital

🇯🇵

Hiroshima, Japan

Kyoto University Hospital

🇯🇵

Kyoto, Japan

Okayama University Hospital

🇯🇵

Okayama, Japan

University of Occupational and Environmental Health Hospital

🇯🇵

Kita-Kyushu, Fukuoka, Japan

Gunma University Hospital

🇯🇵

Maebashi, Gunma, Japan

Asahikawa Medical University Hospital

🇯🇵

Asahikawa, Hokkaido, Japan

Hokkaido Social Service Association Obihiro Hospital

🇯🇵

Obihiro, Hokkaido, Japan

Hokkaido University Hospital

🇯🇵

Sapporo, Hokkaido, Japan

Iwate Medical University Hospital

🇯🇵

Morioka, Iwate, Japan

Osaka Medical Center and Research Institute for Maternal and Child Health

🇯🇵

Izumi, Osaka, Japan

Seirei Hamamatsu General Hospital

🇯🇵

Hamamatsu, Shizuoka, Japan

Federal Officers' Mutual Aid Association Toranomon Hospital

🇯🇵

Minato-ku, Tokyo, Japan

Tottori University Hospital

🇯🇵

Yonago, Tottori, Japan

Yamanashi University Hospital

🇯🇵

Chuo, Yamanashi, Japan

Kumamoto University Hospital

🇯🇵

Kumamoto, Japan

Osaka Employees' Pension Hospital

🇯🇵

Osaka, Japan

National Center for Child Health and Development

🇯🇵

Setagaya-ku, Tokyo, Japan

© Copyright 2025. All Rights Reserved by MedPath